A detailed history of Rothschild & CO Asset Management Us Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Rothschild & CO Asset Management Us Inc. holds 1,482,940 shares of BMY stock, worth $85.7 Million. This represents 1.63% of its overall portfolio holdings.

Number of Shares
1,482,940
Previous 1,453,644 2.02%
Holding current value
$85.7 Million
Previous $103 Million 3.23%
% of portfolio
1.63%
Previous 1.77%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$68.48 - $81.09 $2.01 Million - $2.38 Million
29,296 Added 2.02%
1,482,940 $107 Million
Q3 2022

Nov 07, 2022

SELL
$0.13 - $76.84 $13,389 - $7.91 Million
-102,993 Reduced 6.62%
1,453,644 $103 Million
Q2 2022

Aug 09, 2022

SELL
$72.62 - $79.98 $4.65 Million - $5.12 Million
-64,019 Reduced 3.95%
1,556,637 $120 Million
Q1 2022

May 13, 2022

BUY
$61.48 - $73.72 $2 Million - $2.4 Million
32,524 Added 2.05%
1,620,656 $118 Million
Q4 2021

Feb 11, 2022

SELL
$53.63 - $62.52 $484,332 - $564,618
-9,031 Reduced 0.57%
1,588,132 $99 Million
Q3 2021

Nov 09, 2021

SELL
$59.17 - $69.31 $1.55 Million - $1.82 Million
-26,240 Reduced 1.62%
1,597,163 $94.5 Million
Q2 2021

Aug 16, 2021

BUY
$61.91 - $67.42 $3.66 Million - $3.99 Million
59,149 Added 3.78%
1,623,403 $108 Million
Q1 2021

May 14, 2021

BUY
$59.34 - $66.74 $14.8 Million - $16.7 Million
249,731 Added 19.0%
1,564,254 $98.8 Million
Q4 2020

Feb 08, 2021

BUY
$57.74 - $65.43 $40.1 Million - $45.4 Million
694,428 Added 111.99%
1,314,523 $81.5 Million
Q3 2020

Nov 09, 2020

BUY
$57.43 - $63.64 $35 Million - $38.8 Million
609,574 Added 5793.88%
620,095 $37.4 Million
Q3 2019

Nov 08, 2019

BUY
$42.77 - $50.71 $86,181 - $102,180
2,015 Added 23.69%
10,521 $534,000
Q2 2019

Jul 25, 2019

BUY
$44.62 - $49.34 $51,669 - $57,135
1,158 Added 15.76%
8,506 $386,000
Q4 2018

Feb 05, 2019

SELL
$48.76 - $63.23 $40,031 - $51,911
-821 Reduced 10.05%
7,348 $382,000
Q2 2018

Aug 07, 2018

BUY
$50.53 - $62.98 $89,892 - $112,041
1,779 Added 27.84%
8,169 $452,000
Q1 2018

May 08, 2018

BUY
$59.92 - $68.98 $21,211 - $24,418
354 Added 5.86%
6,390 $404,000
Q3 2017

Nov 08, 2017

BUY
$55.23 - $63.74 $333,368 - $384,734
6,036
6,036 $385,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Rothschild & CO Asset Management Us Inc. Portfolio

Follow Rothschild & CO Asset Management Us Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild & CO Asset Management Us Inc., based on Form 13F filings with the SEC.

News

Stay updated on Rothschild & CO Asset Management Us Inc. with notifications on news.